1.
Intern Med J
; 50(12): 1559-1562, 2020 12.
Article
in English
| MEDLINE | ID: covidwho-991429
ABSTRACT
Hydroxychloroquine is being used for COVID-19 symptoms and in clinical trials, but can cause a toxic myopathy that leads to muscle weakness. A review of skeletal muscle biopsies from patients with hydroxychloroquine myopathy gives pointers of steps that can be taken to diagnose this toxic myopathy early and help differentiate it from COVID-19-related muscle weakness.